Skip to content

Clinical trials

Phase 1/2 Pneumonia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pneumonia Phase: Phase 1/2 Country / region: United States Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20031
20121
20203
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aridis Pharmaceuticals, Inc.1
Celularity Incorporated1
Clarassance, Inc.1
Emory University1
FDA Office of Orphan Products Development1
Kaiser Permanente1
Mirror Biologics, Inc.1
Rapa Therapeutics LLC1
University of Maryland, Baltimore1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pneumonia9
COVID-195
Respiratory Distress Syndrome3
Coronavirus Infections2
Lung Diseases2
Virus Diseases2
Acute Lung Injury1
Bronchiolitis Obliterans1
Bronchopulmonary Dysplasia1
Coronaviridae Infections1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.